查看购物车
  • Traditional Chinese
  • Japanese
干眼症治疗市场（2025）：全球分析（2024-2030）
市场调查报告书
商品编码
1876881

干眼症治疗市场（2025）：全球分析（2024-2030）

2025 Dry Eye Pharmaceuticals Market Report: Global Analysis for 2024 to 2030
出版日期: | 出版商: Market Scope, LLC | 英文 | 商品交期: 最快1-2个工作天内

价格
简介目录

"干眼症治疗市场（2025）报告" 对全球干眼症药物市场进行了全面分析，检视了该疾病的盛行率、诊断和治疗现状。本报告深入涵盖了人工泪液、抗发炎眼药水、杀螨剂、泪液蒸发抑制剂、黏蛋白分泌促进剂以及其他处方药和非处方药，并对2030年之前的区域需求、销售额和市场表现进行了详细预测。

本报告基于数据，对干眼症市场的现状和成长潜力进行了评估，重点关注新产品开发、新兴给药方式和不断扩展的药物研发管线。报告提供了七个主要区域的全球和区域预测，涵盖了竞争格局、监管差异和治疗趋势。报告中也介绍了23家主要公司及其在干眼症市场的策略定位。

目录：

"2025年干眼症治疗市场报告" 评估了用于治疗干眼症的处方药和非处方药市场的发展趋势。该报告结合了流行病学数据、疾病特征和五年市场预测，概述了眼科领域中成长最快的类别之一的未来机会。

本报告涵盖的主题包括：

  • 干眼症概述： 正常泪液功能解剖、症状、危险因子、诊断标准和 DEWS 分类
  • 盛行率和风险分析： 美国、西欧、日本、中国、印度、拉丁美洲和其他市场的区域估计和风险概况
  • 诊断与治疗趋势： 诊断方法、区域实践差异与严重程度区隔
  • 治疗途径和产品区隔： 润滑剂、止汗剂、发炎和缓释疗法分析
  • 全球和区域市场预测： 单位需求、收入预测、依产品类型和公司划分的市场占有率以及消费趋势2030
  • 药物研发管线分析深入分析30余种在研化合物及新兴药物递送技术
  • 主要竞争对手概况深入分析23家领先的干眼症治疗药物生产商，包括产品组合、策略及前景
简介目录

The "2025 Dry Eye Pharmaceuticals Market Report" provides a comprehensive analysis of the global market for dry eye therapeutics, examining the disease's prevalence, diagnosis, and treatment landscape. The report provides in-depth coverage of artificial tears, anti-inflammatory drops, miticides, tear evaporation inhibitors, mucin secretagogues, and other prescription and over-the-counter products-with detailed forecasts of unit demand, sales revenue, and market performance by region through 2030.

The report offers a data-driven assessment of the current dry eye marketplace and its growth potential, highlighting new product development, emerging drug-delivery methods, and the expanding pharmaceutical pipeline. Global and regional forecasts are presented for seven major regions, with coverage of competitive dynamics, regulatory differences, and therapeutic trends. Profiles are provided for 23 leading companies and their strategic positioning within the dry eye market.

Contents:

The "2025 Dry Eye Pharmaceuticals Market Report" evaluates the evolving market for prescription and over-the-counter therapies used in the management of dry eye disease. The report combines epidemiological data, disease characterization, and five-year market projections to outline future opportunities in one of ophthalmology's fastest-growing categories.

The following topics are covered in the report:

  • Comprehensive overview of dry eye disease: anatomy of normal tear function, symptoms, risk factors, diagnostic criteria, and DEWS classification
  • Prevalence and risk analysis: regional estimates and risk profiles for the US, Western Europe, Japan, China, India, Latin America, and other global markets
  • Diagnosis and care trends: approaches to diagnosis, regional practice variations, and severity segmentation
  • Treatment pathways and product segmentation: analysis of lubricants, anti-inflammatories, and sustained-release therapeutics
  • Global and regional market forecasts: unit demand, revenue forecasts, market share by product type and company, and consumption trends through 2030
  • Pharmaceutical pipeline analysis: detailed review of more than 30 investigational compounds and emerging drug-delivery technologies
  • Profiles of major competitors: in-depth profiles of 23 leading dry eye pharmaceutical manufacturers, including their portfolios, strategies, and outlook